Table 1.
Clinical and Laboratory Characteristics of Study Subjects*
| Variables | Case group (n=85) | Control group (n=85) |
|---|---|---|
| Sex (female), n (%) | 72 (85) | 72 (85) |
| Age (years) | 31.24 (11.36) | 31.94 (12.27) |
| BMI (kg/m2) | 27.9 (5.7) | 27.1 (5.8) |
| TSH (mIU/l) | 2.2 (1.1) | 2.1 (1.3) |
| Ft4 (ng/ml) | 1.1 (0.3) | 1.0 (0.2) |
| FT3 (pg/ml) | 2.7 (0.7) | 2.6 (0.5) |
| Anti TPO (IU/mL) | 6.3 (4.1) | 5.6 (4.7) |
| Anti Tg (IU/mL) | 27.2 (20.9) | 25.4 (27.3) |
| 25 OHD (ng/ml) | 8.0 (3.7) | 13.4 (7.9) |
| Vitamin D deficiency, n(%) | 30 (100) | 25 (83.3) |
*
Mean (SD), except where otherwise indicated; BMI, body mass index; TSH, thyroid stimulating hormone; FT4, free thyroxin; FT3, free triiodothyronin; Anti-TPO, antithyroid peroxidase; Anti-Tg, antithyroglobulin; 25 OHD, 25 hydroxy vitamin D.